OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma
Hongjun Yu, Chaoqun Wang, Shanjia Ke, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11

Showing 11 citing articles:

The role of competing endogenous RNA network in the development of hepatocellular carcinoma: potential therapeutic targets
Ziwei Tang, Xue Li, Yanfeng Zheng, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 15

Bioreactor-based stem cell therapy for liver fibrosis
Mengchao Yan, Jia Yao, Ye Xie, et al.
Biofabrication (2024) Vol. 16, Iss. 2, pp. 025028-025028
Open Access | Times Cited: 2

Role of N6‐methyladenosine RNA modification in cancer
Yi Qu, Nannan Gao, Shengwei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 2

Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma
Fukai Wen, Fanshuai Meng, Xuewen Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4

Proteomic and metabolomic analysis of the serum of patients with tick-borne encephalitis
Yandan Du, LePing Ou, HaiJun Zheng, et al.
Journal of Proteomics (2024) Vol. 298, pp. 105111-105111
Closed Access | Times Cited: 1

Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening
Weichen Yuan, Wei Xu, Xin Xu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

<i>CYB5D2</i> inhibits the malignant progression of hepatocellular carcinoma by inhibiting <i>TGF-β</i> expression and epithelialmesenchymal transition
Dong Jiang, 智 岡崎, Zhiying Xu, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 33, Iss. 3, pp. 709-722
Closed Access

Page 1

Scroll to top